Our finding that C. albicans interacts with TIGIT has the potential to offer the benefit of using monoclonal antibodies, such as anti-TIGIT antibodies, which could serve as a remedy for cancer and may confer protection against fungal infections. The gene discussed is TIGIT; the disease is cancer.